Gujarat Attracts Global Healthcare Brands
Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories […]
Say something
Gujarat perhaps going to be the next hub of Indian healthcare enterprise. After Vicks and Colgate Palmolive, US-based Abbott Laboratories […]
Glenmark Pharmaceuticals has initiated voluntary recall of a skin ointment from the US after the drug exceeded the permissible impurity level.
Pfizer considers outsourcing manufacturing to India, ChinaUS-based pharmaceutical giant, Pfizer, is looking to cut costs by outsourcing as much as […]
The John Theurer Cancer Center at Hackensack University Medical Center in New Jersey, US, has unveiled a US$130m cancer facility.
The largest integrated delivery network in southern New Jersey, Virtua, is rolling out new information technology for operating rooms in nine facilities.
Perot Systems will significantly bolster its health-care interests after acquiring Tellurian Networks, a managed services provider of electronic medical records (EMR) and practice management (PM) applications.
IBM has announced new services to help healthcare organisations implement wireless mobility solutions to meet their 21st century objectives towards efficiency and quality.
Venture capitalists pumped a record USD 9.1 billion into privately-held US biotechnology and medical device companies last year, in hopes of making discoveries they can sell to larger drugmakers.
[This article was published in the January 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
News
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
Pfizer, a US-based pharmaceutical giant, is looking to cut costs by outsourcing as much as 30 per cent of its manufacturing to facilities in Asia, particularly in India and China.
Nicholas Piramal (NPIL) has reportedly signed a research deal potentially worth a maximum revenue of USD 350 million with US pharmaceutical giant Merck & Co to carry out early discovery and development of two new cancer drugs, the two companies said on Monday.